MEI Pharma Confirms Receipt Of Unsolicited Acquisition Proposal
Portfolio Pulse from Benzinga Newsdesk
MEI Pharma has received an unsolicited acquisition proposal from a group represented by Anson Advisors Inc. and Cable Car Capital LLC, offering at least $8.00 per share in cash, plus a contingent value right for 80% of net proceeds from any license or disposition of the company's clinical assets.
May 30, 2023 | 9:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MEI Pharma has received an unsolicited acquisition proposal, which could lead to a potential increase in the company's stock price.
The unsolicited acquisition proposal from Anson Advisors Inc. and Cable Car Capital LLC offers a premium price for MEI Pharma's shares, which could lead to an increase in the stock price. Additionally, the contingent value right for 80% of net proceeds from any license or disposition of the company's clinical assets could further increase the value for shareholders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100